Thus, given the regulatory effects of NPY on stem cell and the multifaceted beneficial effects on ischemic myocardium, it can be speculated that a combined treatment of stem cells with NPY may be a novel strategy for ischemic heart disease including myocardial infarction. Here, NPY is linked to coronary artery disorder.